Cantourage Group SE

Cantourage Group SE

News

22.12.2025 09:00:21

Original-Research: Cantourage Group SE (von NuWays AG): BUY

19.12.2025 14:39:54

EQS-Adhoc: Cantourage Group SE expects EBITDA for 2025 to exceed current market expectations based on preliminary figures

11.12.2025 09:00:15

Original-Research: Cantourage Group SE (von NuWays AG): BUY

09.12.2025 08:00:03

EQS-News: Cantourage appoints new member to its Management Board: Monique Jaqqam becomes Chief Financial Officer – Supervisory Board prolongs CEO Philip Schetter's mandate by five years

04.11.2025 12:00:03

EQS-News: Cantourage strengthens market presence in Poland with flower variety “Gelato 33”

04.11.2025 09:00:14

Original-Research: Cantourage Group SE (von NuWays AG): Buy

30.10.2025 10:08:23

EQS-News: Q3 2025: Cantourage delivers strong operating performance in a challenging regulatory market environment

15.10.2025 15:49:13

EQS-News: Cabinet decision on the Medical Cannabis Act meets broad criticism / Cantourage expects changes and prepares to expand its “Telecan” platform

08.10.2025 13:01:02

EQS-News: Cantourage is responding to potential developments resulting from new legal regulations with focused internationalization and strategic product diversification

01.10.2025 09:47:53

EQS-News: Cantourage Strengthens Capital Markets Presence: New Head of Investor Relations and Strategic Focus on Europe

Downloads

Latest Research

Initiation

Latest Research

Christian Sandherr

December 22 2025

22 Dec 25

FY25 EBITDA to come in ahead of market estimates

Christian Sandherr

December 11 2025

11 Dec 25

Cantourage strengthening its leadership structure

Christian Sandherr

November 04 2025

04 Nov 25

Q3 prelims: Growth remains strong // int. expansion ongoing

Preview / Review

Christian Sandherr

September 05 2025

05 Sep 25

Regulatory uncertainty and oversupply weighing on momentum

Christian Sandherr

July 11 2025

11 Jul 25

Ongoing strong operations, CEO with temporary personal leave